The SWORD Study: A New Two-Drug Combo for HIV The SWORD Study: A New Two-Drug Combo for HIV
Dr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.Medscape HIV/AIDS
Source: Medscape Today Headlines - Category: Consumer Health News Tags: HIV/AIDS Commentary Source Type: news